Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific

American Journal of Tropical Medicine and Hygiene

Volumn 68, Issue 1, 2003, Pages 97-101

  Alloueche, Ali ^a   Milligan, Paul ^b   Conway, David J ^a   Pinder, Margaret ^b   Bojang, Kalifa ^b   Doherty, Tom ^b   Tornieporth, Nadia ^c   Cohen, Joe ^c   Greenwood, Brian M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCUMSPOROZOITE PROTEIN; EPITOPE; FANSIDAR; HEPATITIS B SURFACE ANTIGEN; MALARIA VACCINE; RECOMBINANT PROTEIN; RTS,S/AS02 MALARIA VACCINE; UNCLASSIFIED DRUG; CIRCUMSPOROZOITE PROTEIN, PROTOZOAN; PROTOZOAL DNA; PROTOZOAL PROTEIN; RECOMBINANT VACCINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GAMBIA; GENOTYPE; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALARIA; MALE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; STRAIN DIFFERENCE; T LYMPHOCYTE; ADOLESCENT; ANIMAL; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; IMMUNOLOGY; MALARIA FALCIPARUM; MIDDLE AGED; POISSON DISTRIBUTION;

HEPATITIS B VIRUS; PLASMODIUM FALCIPARUM; PROTOZOA;

ADOLESCENT; ADULT; ANIMALS; DNA, PROTOZOAN; EPITOPES; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HEPATITIS B SURFACE ANTIGENS; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; POISSON DISTRIBUTION; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; VACCINES, SYNTHETIC; VARIATION (GENETICS);

EID: 0037267842     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2003.68.97     Document Type: Article

References (18)

1. Graves P, Gelband H, 2001. Vaccines for preventing malaria (Cochrane Review). The Cochrane Library 1. Oxford: Update Software.
2. Guiguemde TR, Sturchler D, Ouedraogo JB, Drabo M, Etlinger H, Douchet C, Gbary AR, Haller L, Kambou S, Fernex M, 1990. Vaccination against malaria: initial trial with an antisporozoite vaccine, (NANP)3-TT (RO 40-2361) in Africa (Bobo-Dioulasso, Burkina Faso). Bull Soc Pathol Exot 8: 217-227.
3. Reber-Liske R, Salako LA, Matile H, Sowunmi A, Sturchler D, 1995. NANP 19-5.1. A malaria vaccine field trial in Nigerian children. Trop Geogr Med 47: 61-63.
4. Sherwood JA, Copeland RS, Taylor KA, Abok K, Oloo AJ, Were JB, Strickland GT, Gordon DM, Ballou WR, Bales JD, Wirtz RA, Wittes J, Gross M, Que JU, Cryz SJ, Oster CN, Roberts CR, Sadoff JC, 1996. Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria in Kenya. Vaccine 14: 817-827.
5. Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, Wellde BT, Garcon N, Krzych U, Marchand M, and the RTS,S Malaria Vaccine Evaluation Group. 1997. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N Engl J Med 336: 86-91.
6. Stoute JA, Kester KE, Krzych U, Wellde BT, Hall T, White K, Glenn G, Ockenhouse CF, Garcon N, Schwenk R, Lanar DE, Sun P, Momin P, Wirtz RA, Golenda C, Slaoui M, Wortmann G, Holland C, Dowler M, Cohen J, Ballou WR, 1998. Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine. J Infect Dis 178: 1139-1144.
7. Kester KE, McKinney DA, Tornieporth N, Ockenhouse CF, Heppner DG, Hall T, Krzych U, Delchambre M, Voss G, Dowler MG, Palensky J, Wittes J, Cohen J, Ballou WR, and the RTS,S Malaria Vaccine Evaluation Group, 2001. Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria. J Infect Dis 183: 640-647.
8. Lalvani A, Moris P, Voss G, Pathan AA, Kester KE, Brookes R, Lee E, Koutsoukos M, Plebanski M, Delchambre M, Flanagan KL, Carton C, Slaoui M, Van Hoecke C, Ballou WR, Hill AV, Cohen J, 1999. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine. J Infect Dis 180: 1656-1664.
9. Bojang K, Milligan PJM, Pinder M, Vigneron L, Alloueche A, Kester KE, W. Ballou WR, Conway DJ, Reece WHH, Gothard P, Yamuah L, Delchambre M, Voss G, Greenwood BM, Hill A, McAdam KPWJ, Tornieporth N, Cohen JD, Doherty T, and the RTS,S malaria vaccine trial team, 2001. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 358: 1927-1934
10. Beck HP, Felger I, Huber W, Steiger S, Smith T, Weiss N, Alonso P, Tanner M, 1997. Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66. J Infect Dis 175: 921-926.
11. Haywood M, Conway DJ, Weiss H, Metzger W, D'Alessandro U, Snounou G, Targett G, Greenwood BM, 1999. Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66. Trans R Soc Trop Med Hyg 93: 65-68.
12. Alloueche A, Silveira H, Conway DJ, Bojang K, Doherty T, Cohen J, Pinder M, Greenwood BM, 2000. High-throughput sequence typing of T-cell epitope polymorphisms in Plasmodium falciparum circumsporozoite protein. Mol Biochem Parasitol 106: 273-282.
13. Viriyakosol S, Siripoon N, Petcharapirat C, Petcharapirat P, Jarra W, Thaithong S, Brown KN, Snounou G, 1995. Genotyping of Plasmodium falciparum isolates by the polymerase chain reaction and potential uses in epidemiological studies. Bull World Health Organ 73: 85-95.
14. Cuzick J, 1985. A Wilcoxon-type test for trend. Stat Med 4: 87-90.
15. Cuzick J, 1985. A method for analysing case-control studies with ordinal exposure variables. Biometrics 41: 609-621.
16. Zavala F, Cochrane AH, Nardin EH, Nussenzweig RS, Nussenzweig V, 1983. Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes. J Exp Med 157: 1947-1957.
17. Herrington D, Davis J, Nardin E, Beier M, Cortese J, Eddy H, Losonsky G, Hollingdale M, Sztein M, Levine M, Nussenzweig RS, Clyde D, Edelman R, 1991. Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. Am J Trop Med Hyg 45: 539-547.
18. Nardin EH, Nussenzweig RS, 1993. RS T cell responses to preerythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Annu Rev Immunol 17: 687-727.